Corrigendum to: Post-treatment neutrophil to lymphocyte ratio as a prognostic tool in patients treated with tocilizumab for severe COVID-19 pneumonia - a single center experience

Marija Gomerčić Palčić^{1

2}, Hana Matijaca³, Ivan Kruljac⁴, Lucija Vusić^{1

2

3

4

5

6

7

8

9}, Vedran Hostić⁵, Luka Vrbanić², Fanika Mrsić⁶, Radovan Zrilić⁷, Ivana Ćelap⁸, Petar Gaćina^{3

9}

Affiliations

¹ School of Medicine, University of Zagreb, Zagreb, Croatia.
² Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Pulmonology, Zagreb, Croatia.
³ Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Hematology, Zagreb, Croatia.
⁴ Solmed Group, Department: Poliklinika Solmed, Zagreb, Croatia.
⁵ Department of Anesthesiology, Intensive Care Medicine and Pain Management, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
⁶ Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Clinical Immunology and Rheumatology, Zagreb, Croatia.
⁷ Polyclinic for Respiratory Diseases, Dom zdravlja Zagreb - Zapad, Zagreb, Croatia.
⁸ Department of Clinical Chemistry, Sestre milosrdnice University Hospital Center, Croatia.
⁹ School of Dental Medicine, University of Zagreb, Zagreb, Croatia.

Published Erratum

Marija Gomerčić Palčić et al. Biochem Med (Zagreb). 2023.

. 2023 Oct 15;33(3):031201.

doi: 10.11613/BM.2023.031201.

¹ School of Medicine, University of Zagreb, Zagreb, Croatia.
² Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Pulmonology, Zagreb, Croatia.
³ Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Hematology, Zagreb, Croatia.
⁴ Solmed Group, Department: Poliklinika Solmed, Zagreb, Croatia.
⁵ Department of Anesthesiology, Intensive Care Medicine and Pain Management, Sestre milosrdnice University Hospital Center, Zagreb, Croatia.
⁶ Department of Internal Medicine, Sestre milosrdnice University Hospital Center, Division of Clinical Immunology and Rheumatology, Zagreb, Croatia.
⁷ Polyclinic for Respiratory Diseases, Dom zdravlja Zagreb - Zapad, Zagreb, Croatia.
⁸ Department of Clinical Chemistry, Sestre milosrdnice University Hospital Center, Croatia.
⁹ School of Dental Medicine, University of Zagreb, Zagreb, Croatia.

Abstract

[This corrects the article DOI: 10.11613/BM.2023.020704.].

Croatian Society of Medical Biochemistry and Laboratory Medicine.

Post-treatment neutrophil to lymphocyte ratio as a prognostic tool in patients treated with tocilizumab for severe COVID-19 pneumonia - a single center experience.
Palčić Marija G, Hana M, Ivan K, Lucija V, Vedran H, Luka V, Mrsić F, Radovan Z, Ivana Ć, Petar G. Palčić Marija G, et al. Biochem Med (Zagreb). 2023 Jun 15;33(2):020704. doi: 10.11613/BM.2023.020704. Biochem Med (Zagreb). 2023. PMID: 37324114 Free PMC article.